Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Wire Compound in Medical Elastomer Range Fully Compliant With Medical Requirements

February 3, 2011 6:42 am | Product Releases | Comments

The first wire and cable compound in the Medalist family of medical elastomers is formulated and produced in accordance with stringent medical-industry requirements yet draws on technology with a long track record of success...

CVS Caremark 4Q profit falls 2 percent

February 3, 2011 5:45 am | by The Associated Press | News | Comments

Drugstore chain and pharmacy benefits manager CVS Caremark Corp. said Thursday that its profit fell 2 percent in the fourth quarter on lower revenue because of client losses and fewer Medicare prescription drug program members.The company also offered an estimate for adjusted earnings for this...

Lilly and JDRF partner to fund regenerative medicine research in type 1 diabetes

February 3, 2011 5:36 am | by EurekAlert | News | Comments

(Juvenile Diabetes Research Foundation International) Eli Lilly and Company and the Juvenile Diabetes Research Foundation today announced that they have signed an agreement to fund early-stage research that could enable patients with type 1 diabetes to regenerate insulin-producing...

TOPICS:
Advertisement

Adapting technology to elderly people

February 3, 2011 5:36 am | by EurekAlert | News | Comments

(EUREKA) With the numbers of people aged 65 and over growing, the costs to the state to care for or assist them are set to continue rising across the European Union. With this backdrop, two companies have combined their differing expertise, with the help of Eureka funding, to...

TOPICS:

Concert Pharmaceuticals, Walter Reed partner on seizure treatment

February 3, 2011 5:32 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Concert Pharmaceuticals Inc. today announced that it has signed an agreement to work with the Walter Reed Army Institute of Research to conduct preclinical testing of a Concert drug compound in treating seizures stemming from traumatic brain injuries.

TOPICS:

Generex Oncology Receives New Patent for AE37 Immunotherapeutic Cancer Vaccine(2)

February 3, 2011 5:31 am | by Bio-Medicine.Org | News | Comments

WORCESTER, Mass., Feb. 3, 2011 /- Generex Biotechnology Corporation ( www.generex.com ) (OTC Bulletin Board: GNBT ), together with its wholly-owned immunotherapeutic vaccines subsidiary, Antigen Express, Inc. ( www.antigenexpress.com ), announced today that Antigen Express has received a...

TOPICS:

Developer's Kits Available for Miniature M3-L Closed-Loop Linear Motion Module

February 3, 2011 5:20 am | New Scale Technologies, Inc. | Product Releases | Comments

New Scale Technologies announces that developer's kits for its miniature M3-L closed-loop linear motion module are available for purchase online, shipping from stock.

Kit Enables Evaluation of Bluetooth Connectivity in Embedded Designs

February 3, 2011 5:16 am | Microchip Technology, Inc. | Product Releases | Comments

Microchip Technology Inc., a leading provider of microcontroller, analog, and Flash-IP solutions, offers the Microchip Bluetooth Evaluation Kit, which includes CandleDragon Inc.’s dotstack demonstration Bluetooth Stack.

Advertisement

Smallest Continuous-Duty Scroll Compressor for Battery-Powered Equipment

February 3, 2011 5:09 am | Product Releases | Comments

Air Squared, the world's only maker of sub-1-hp scroll compressors, has developed the world's smallest continuous-duty, oil-free scroll compressor, delivering 48 percent efficiency...

Mednax 4Q profit rises 9 percent on revenue

February 3, 2011 4:45 am | by The Associated Press | News | Comments

National physician group Mednax Inc. said Thursday that its fourth-quarter profit rose 9 percent on a boost in revenue.Mednax earned $53.8 million, or $1.12 per share, up from $50.4 million, or $1.07 per share, in the same quarter last year. Revenue rose 10.6 percent to $368.5 million from...

Discovery May Lead to Turning Back the Clock on Ovarian Cancer

February 3, 2011 4:38 am | by Georgia Tech Institute of Technology | News | Comments

Cancer researchers have discovered that a type of regulatory RNA may be effective in fighting ovarian cancer. This new discovery may allow physicians to turn back the clock of the tumor's life cycle to a phase where traditional chemotherapy can better do its job.

Ceregene Advances Phase 2b CERE-120 (AAV2-neurturin) Trial in Parkinson's Disease

February 3, 2011 4:36 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Feb. 3, 2011 /- Ceregene, Inc., a biopharmaceutical company, announced today that it is progressing with enrollment and dosing in its CERE-120 (AAV2-neurturin) Phase 2b multi-center, sham-surgery, double-blinded controlled trial in Parkinson's disease.  This trial was...

TOPICS:

Pacira Pharmaceuticals, Inc. Announces Pricing of Its Initial Public Offering

February 3, 2011 4:36 am | by Bio-Medicine.Org | News | Comments

PARSIPPANY, N.J., Feb. 3, 2011 /- Pacira Pharmaceuticals, Inc. (Nasdaq: PCRX ), an emerging specialty pharmaceutical company, today announced the pricing of its initial public offering of 6,000,000 shares of its common stock at $7.00 per share, before underwriting discounts and...

TOPICS:

Valeant Launches Senior Notes Offering

February 3, 2011 4:36 am | by Bio-Medicine.Org | News | Comments

MISSISSAUGA, Ontario, Feb. 3, 2011 /- Valeant Pharmaceuticals International, Inc. (NYSE: VRX ) (TSX: VRX) (the "Company") announced today that Valeant Pharmaceuticals International ("Valeant"), its wholly owned indirect subsidiary, launched its offer of approximately $650 million...

TOPICS:

BioNeutral Group Announces the Formation of Kentucky-Based BioNeutral Services, Inc. and the Appointment of Frank Battafarano as Chairman and CEO of BioNeutral Services, Inc.

February 3, 2011 4:36 am | by Bio-Medicine.Org | News | Comments

NEWARK, N.J., Feb. 3, 2011 /- BioNeutral Group, Inc. (OTC Bulletin Board: BONU ), a specialty life science technology-based company, today announced the formation of BioNeutral Services, Inc., a wholly owned subsidiary of BioNeutral Group, Inc., and the appointment of Frank Battafarano as...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading